French drugmaker Sanofi and Britain’s GlaxoSmithKline will supply 200 million doses of their Covid-19 candidate vaccine to a global inoculation scheme backed by the World Health Organization.
Some 172 countries are engaging with the COVAX facility designed to ensure equitable access to Covid-19 vaccines, the World Health Organization said, but more funding is needed and countries need now to make binding commitments.
Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for Covid-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said.
More than 75 countries expressed interest in joining the COVAX financing scheme designed to guarantee fast and equitable access globally to Covid-19 vaccines, the GAVI vaccines alliance said,
A summit hosted by British Prime Minister Boris Johnson is expected to set a goal of at least $7.4 billion to go to Gavi, the Vaccine Alliance.